期刊文献+

痛泻要方对内脏高敏感大鼠肠道肥大细胞及细胞因子表达的影响 被引量:12

Effect of Tongxie Yaofang on Intestinal Mast Cells and Cytokine Expression of Rats with Visceral Hypersensitivity
原文传递
导出
摘要 目的观察痛泻要方对内脏高敏感大鼠肠道肥大细胞(mast cell,MC)及细胞因子表达的影响,探讨痛泻要方治疗内脏高敏感的作用及其机制。方法采用随机数字表法将30只成年雄性SD大鼠随机分成空白对照组、模型组及中药治疗组,每组10只,模型组及中药治疗组以结直肠扩张联合束缚刺激建立大鼠内脏高敏感模型,以腹部收缩反射(abdominal withdrawal reflex,AWR)评估大鼠内脏敏感性,模型构建成功后第2日中药治疗组予痛泻要方4 g/(kg·d)灌胃4周,模型组予以等量生理盐水灌胃4周,空白对照组大鼠不予任何刺激。4周后采用甲苯胺蓝染色法计数回盲部结肠黏膜MC,采用E LISA法检测血清及肠黏膜IL-4、IL-9表达,Western blot法检测肠黏膜蛋白酶激活受体-2(PAR-2)蛋白表达。结果与空白对照组大鼠比较,模型组大鼠内脏敏感性升高,回盲部MC增多,血清及肠黏膜中IL-4、IL-9及PAR-2蛋白表达水平升高(P<0.05);与模型组比较,中药治疗组大鼠内脏敏感性显著降低,MC数量减少,肠黏膜PAR-2蛋白表达下降(均P<0.05),大鼠肠黏膜IL-4及血清IL-9表达水平亦明显降低(P<0.05)。结论痛泻要方可能通过作用于MC相关细胞因子,减少MC脱颗粒,从而降低内脏高敏感。 Objective To observe the effect of Tongxie Yaofang(TY) on the number of mast cells(MCs) and the expression of cytokines in rats with visceral hypersensitivity,and to explore roles of TY in treating visceral hypersensitivity and its possible mechanism.Methods Totally 30 male adult Sprague Dawley(SD) rats were randomly divided into the blank control group,the model group,and the TY treatment group,10 in each group.The irritable bowel syndrome(IBS) rat model was established by combining colorectal distention with restraint stress in the TY treatment group and the model group.The visceral hypersensitivity was assessed by abdominal withdrawal reflex(AWR).From the 2nd day of successful modeling,rats in the treatment group were admiministered with TY at the daily dose of 4 g/kg for4 successive weeks.Equal volume of normal saline was given to rats in the model group for 4 successive weeks.No treatment was given to rats in the blank control group.Four weeks later the number of MCs was counted by using toluidine blue staining.The expression of interleukin-4(IL-4) and interleukin-9(IL-9) both in colonic mucosa and serum were measured by enzyme linked immunosorbent assay(ELISA),and the expression of protease-activated receptor type 2(PAR-2) was detected by Western blot.Results Compared with the blank control group,the visceral sensitivity was significantly elevated,the number of MCs in the ileocecal junction increased,and the expression of IL-4,IL-9,and PAR-2 in serum and the colonic mucosa significantly increased(P0.05).Compared with the model group,the visceral sensitivity significantly decreased,the number of MCs reduced,and the expression of PAR-2 in the colonic mucosa significantly reduced(all P〈0.05),and the expression of IL-4 in colonic mucosa and IL-9 in serum were obviously reduced in the TY treatment group(P〈0.05).Conclusion TY might improve the visceral hypersensitivity by acting on MCs related cytokines and reducing degranulation of MCs.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2014年第9期1130-1134,共5页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金项目(No.81170348) 浙江省自然科学基金项目(No.LZ12H03001)
关键词 内脏高敏感 肥大细胞 痛泻要方 IL-4 IL-9 蛋白酶激活受体-2 visceral hypersensitivity mast cell Tongxie Yaofang interleukin 4 interleukin 9 protease-activated receptor type 2
  • 相关文献

参考文献23

  • 1Spinelli A. Irritable bowel syndrome[J]. Clin Drug Investig, 2007,27(1): 15 -33.
  • 2Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia [J]. J Neurogastroenterol Motil, 2010,16(4): 389 -400.
  • 3Spiegel BM. The burden of IBS: looking at metrics [J]. Curr Gastroenterol Rep, 2009, 11 (4): 265 - 269.
  • 4Cremon C, Gargano L, Morselli-Labate·AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms [J]. Am J Gastroenterol, 2009,104(2): 392 -400.
  • 5Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome [J]. Gastroenterology, 2007, 132(3): 913 -920.
  • 6Kindt S, Van Oudenhove L, B roekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders [J]. Neurogastroenterol Motil, 2009, 21 (4): 389 -398.
  • 7Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats [J]. Am J Physiol, 1997,273(1 Pt 1): G191-G196.
  • 8Agostini S, Goubern M, Tondereau V, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM 1-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats [J]. Neurogastroenterol Motil, 2012, 24(4): 376-e172.
  • 9AI-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development [J]. Gastroenterology, 2000, 119 (5) : 1276 - 1285.
  • 10Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome [J]. J Clin Invest, 2007, 117 (3): 636 -647.

二级参考文献17

  • 1李冬华,朱飞鹏,李珊珊,王帅,马丛,黄亚娜.疏肝健脾法调控肠易激综合征动物模型胃肠激素水平的研究[J].中国实验方剂学杂志,2008,14(7):20-23. 被引量:20
  • 2王艳梅,李延青,吕国苹,顾晓萌,郭玉婷,左秀丽,张海燕,李君曼,赵宪村.肠易激综合征病人内脏高敏感性的研究[J].中华腹部疾病杂志,2002,2(5):420-422. 被引量:8
  • 3杨云生,周殿元,张万岱,张振书,宋于刚.肠易激综合征回盲部肥大细胞的研究[J].中华内科杂志,1997,36(4):231-233. 被引量:47
  • 4Bouin M, Plouide V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: Sensitivily, speetificity, and predictive values of pain sensory thresholds [ J ]. Gastroenterology ,2002,122(7 ) : 1771.
  • 5Mayer E A, Naliboff B D, Chang L. Coutinho SV1 stress and the gastrointestinal tract V1 stress and irrirable bowel syndromel [ J ]. Am J Physiol Gastrointest Liver Physiol, 2001, 280 (4) : 519.
  • 6Heinrichs S C, Tach Y. Therapeutic potential of CRF receptor antagonists: A gut-brain perspective [ J ]. Expert Opin Investig Drugs, 2001 , 10(4) : 647.
  • 7Williams C L, Villar R G, Peterson J M, et al. Stress-induced changes in intestinal transit in the rat: A model for irritable bowel syndrome[J]. Gastroenterology, 1988,94:611.
  • 8Tache Y, Martincz V, Wang L, et al. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: Implications for irritable bowel syndrome[J]. Br Pharmacol, 2004,141:1321.
  • 9Lejeune F, Millan M J. The CRF1 receptor antagonist, DMP695, abolishes aetivation of locus coeruleus nora drenergic neurones by CRF in anesthetized rats[ J]. Eur Pharmacol, 2003, 464: 127.
  • 10Mathew P,Bhatia S J.Pathogenesis and management of irritable bowel syndrome[J].Trop Gastroenterol,2009,30(1):19.

共引文献43

同被引文献211

引证文献12

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部